Patents/Assignees

Terns Pharmaceuticals, Inc.

12 patents in portfolio

US12528791utility2026
Thyroid Hormone Receptor Beta Agonist Compounds
0 cites
US12485118utility2025
Combinations of GLP-1R and Thrβ Agonists and Methods of Use Thereof
0 cites
US12486261utility2025
Compounds as GLP-1R Agonists
0 cites
US12454524utility2025
(r)-n-(4-(chlorodifluoromethoxy)phenyl)-2-(difluoromethyl)-1-(1-hydroxypropan-2-yl)-7-(pyrimidin-5-yl)-1h-benzo[d]imidazole-5-carboxamide, or a Pharmaceutically Acceptable Salt or Tautomer Thereof, for Treating Certain Leukemias
0 cites
US12410163utility2025
Compounds as GLP-IR Agonists
0 cites
US12398127utility2025
Thyroid Hormone Receptor Beta Agonist Compounds
0 cites
US12378237utility2025
Compounds as GLP-1R Agonists
0 cites
US12378236utility2025
Compounds as GLP-1R Agonists
0 cites
US12378238utility2025
Compounds as GLP-1R Agonists
0 cites
US12378239utility2025
Compounds as GLP-1R Agonists
0 cites
US12240835utility2025
Substituted Benzamides as Intermediates in the Synthesis of Inhibitors of Tyrosine Kinase Enzymatic Activity
0 cites
US12024507utility2024
Compounds as GLP-1R Agonists
0 cites